Literature DB >> 30377567

NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling.

Shuai Wang1, Qian Zhang2, Qinlan Wang1, Qicong Shen2, Xiang Chen2, Zhenyang Li2, Ye Zhou2, Jin Hou2, Bowen Xu2, Nan Li2, Xuetao Cao1,2.   

Abstract

The formation of paraspeckle, a stress-induced nuclear body, increases in response to viral infection or proinflammatory stimuli. Paraspeckle consists of lncRNA (nuclear paraspeckle assembly transcript 1, NEAT1) and protein components including NONO, SFPQ, PSPC1, etc., which are shown to be involved in viral infection and cancer. Both NEAT1 and NONO expression increase in human hepatocellular carcinoma (HCC) samples according to TCGA data. However, the role of paraspeckle in HCC progression needs further identification. IL-6 signaling is well known to contribute to HCC progression. Here we reported that IL-6 signaling increased paraspeckle formation in HCC cells. Destruction of paraspeckle formation by silencing the paraspeckle essential components NEAT1_2 or NONO could suppress IL-6-induced STAT3 phosphorylation in HCC cells, and consequently repressed IL-6-promoted in vitro HCC cell invasion, cell cycle progression and survival. Mechanistically, paraspeckle promotes IL-6-induced STAT3 phosphorylation by binding and trapping peroxiredoxin-5 (PRDX5) mRNA in nucleus, decreasing protein level of PRDX5 which can directly interact with STAT3 and inhibit STAT3 phosphorylation. Besides, glutathione S-transferase P (GSTP1) protein, which inhibits DNA damage and apoptosis through its detoxification and anti-oxidation function, was also trapped within paraspeckles under IL-6 stimulation. Paraspeckle-trapping of both PRDX5 mRNA and GSTP1 protein contributes to IL-6-increased DNA damage in HCC cells. Our results demonstrate that paraspeckle can nuclear entrap the inhibitors of IL-6/STAT3 signaling as well as DNA damage, and then strengthen the promoting effect on HCC progression by IL-6. Therefore, paraspeckle contributes to the inflammation-related HCC progression and might be a potential therapeutic target for HCC.

Entities:  

Keywords:  NEAT1; NONO; Paraspeckle; hepatocellular carcinoma; inflammation; interleukin-6

Year:  2018        PMID: 30377567      PMCID: PMC6205018          DOI: 10.1080/2162402X.2018.1503913

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  58 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.

Authors:  Ji-hang Yuan; Fu Yang; Fang Wang; Jin-zhao Ma; Ying-jun Guo; Qi-fei Tao; Feng Liu; Wei Pan; Tian-tian Wang; Chuan-chuan Zhou; Shao-bing Wang; Yu-zhao Wang; Yuan Yang; Ning Yang; Wei-ping Zhou; Guang-shun Yang; Shu-han Sun
Journal:  Cancer Cell       Date:  2014-04-24       Impact factor: 31.743

Review 3.  Structure and function of histone H3 lysine 9 methyltransferases and demethylases.

Authors:  Swathi Krishnan; Scott Horowitz; Raymond C Trievel
Journal:  Chembiochem       Date:  2011-01-05       Impact factor: 3.164

4.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  Tyrosine-7 in human class Pi glutathione S-transferase is important for lowering the pKa of the thiol group of glutathione in the enzyme-glutathione complex.

Authors:  K H Kong; K Takasu; H Inoue; K Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1992-04-15       Impact factor: 3.575

Review 6.  Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.

Authors:  Marcel Klingenberg; Akiko Matsuda; Sven Diederichs; Tushar Patel
Journal:  J Hepatol       Date:  2017-04-22       Impact factor: 25.083

7.  MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles.

Authors:  Yasnory T F Sasaki; Takashi Ideue; Miho Sano; Toutai Mituyama; Tetsuro Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

Review 9.  The building process of the functional paraspeckle with long non-coding RNAs.

Authors:  Tomohiro Yamazaki; Tetsuro Hirose
Journal:  Front Biosci (Elite Ed)       Date:  2015-01-01

10.  NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing.

Authors:  Li Jiang; Changwei Shao; Qi-Jia Wu; Geng Chen; Jie Zhou; Bo Yang; Hairi Li; Lan-Tao Gou; Yi Zhang; Yangming Wang; Gene W Yeo; Yu Zhou; Xiang-Dong Fu
Journal:  Nat Struct Mol Biol       Date:  2017-08-28       Impact factor: 15.369

View more
  20 in total

1.  Long non-coding RNA AFAP1-AS1 promotes cell growth and inhibits apoptosis by binding to specific proteins in germinal center B-cell-like diffuse large B-cell lymphoma.

Authors:  Hongyu Gao; Ying Sun; Jiawen Chen; Hong Jin; Wei Yang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

3.  Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer.

Authors:  Hongxia Wu; Aiwen Liu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

4.  Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.

Authors:  Kumaravel Mohankumar; Rupesh Shrestha; Stephen Safe
Journal:  Mol Carcinog       Date:  2021-10-26       Impact factor: 4.784

Review 5.  Mechanisms of Long Non-Coding RNAs in Cancers and Their Dynamic Regulations.

Authors:  Xiao-Zhen Zhang; Hao Liu; Su-Ren Chen
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

Review 6.  Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.

Authors:  Lei Zhang; Xiulan Zheng; Wen Cheng; Xuefei Zhang; Lingling Wang; Haixia Li
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

Review 7.  Long Non-Coding RNA in the Pathogenesis of Cancers.

Authors:  Yujing Chi; Di Wang; Junpei Wang; Weidong Yu; Jichun Yang
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

8.  Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.

Authors:  Yan Zhao; Zhi-Xuan Li; Yan-Jing Zhu; Jing Fu; Xiao-Fang Zhao; Ya-Ni Zhang; Shan Wang; Jian-Min Wu; Kai-Ting Wang; Rui Wu; Cheng-Jun Sui; Si-Yun Shen; Xuan Wu; Hong-Yang Wang; Dong Gao; Lei Chen
Journal:  Adv Sci (Weinh)       Date:  2021-03-23       Impact factor: 16.806

9.  A Non-Coding RNA Network Involved in KSHV Tumorigenesis.

Authors:  Julián Naipauer; Martín E García Solá; Daria Salyakina; Santas Rosario; Sion Williams; Omar Coso; Martín C Abba; Enrique A Mesri; Ezequiel Lacunza
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

10.  Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.

Authors:  Jian Zang; Min-Hua Zheng; Xiu-Li Cao; Yi-Zhe Zhang; Yu-Fei Zhang; Xiang-Yu Gao; Yuan Cao; Mei Shi; Hua Han; Liang Liang
Journal:  Cell Commun Signal       Date:  2020-08-26       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.